Aclaris Therapeutics, Inc. (ACRS): Price and Financial Metrics
Aclaris Therapeutics, Inc. (ACRS)
Today's Latest Price: $18.83 USD
Updated Jan 19 4:00pm
Add ACRS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 239 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ACRS Stock Summary
- With a year-over-year growth in debt of -63.35%, Aclaris Therapeutics Inc's debt growth rate surpasses just 4.43% of about US stocks.
- As for revenue growth, note that ACRS's revenue has grown -61.45% over the past 12 months; that beats the revenue growth of just 3.47% of US companies in our set.
- In terms of volatility of its share price, ACRS is more volatile than 94.93% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Aclaris Therapeutics Inc, a group of peers worth examining would be RESN, MRKR, BCDA, XAIR, and CUE.
- ACRS's SEC filings can be seen here. And to visit Aclaris Therapeutics Inc's official web site, go to www.aclaristx.com.
ACRS Stock Price Chart Interactive Chart >
ACRS Price/Volume Stats
| Current price | $18.83 | 52-week high | $19.95 |
| Prev. close | $5.88 | 52-week low | $0.70 |
| Day low | $13.29 | Volume | 114,362,100 |
| Day high | $19.95 | Avg. volume | 10,760,209 |
| 50-day MA | $5.06 | Dividend yield | N/A |
| 200-day MA | $2.88 | Market Cap | 808.16M |
Aclaris Therapeutics, Inc. (ACRS) Company Bio
Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company focused on identifying, developing, and commercializing novel drugs to address unmet needs in dermatology. The company was founded in 2012 and is based in Malvern, Pennsylvania.
Loading social stream, please wait...